Cyto earnings
WebCYTO: Altamira Therapeutics Detailed Earnings Estimate. Get the latest Detailed Estimate from Zacks Investment Research. CYTO: Altamira Therapeutics - Detailed Earnings … WebAltamira Therapeutics (CYTO) has a Smart Score of N/A based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund Activity. ... Altamira Therapeutics’s upcoming earnings report date is Aug 17, 2024 which is in 135 days. How were Altamira Therapeutics’s earnings last quarter? Currently, no data ...
Cyto earnings
Did you know?
WebMar 24, 2024 · Altamira Therapeutics Ltd. (CYTO) consensus earnings estimates: forecast for revenue and EPS, high & low, YoY growth, forward PE and number of analysts. … WebNov 30, 2024 · Altamira Therapeutics (CYTO) reports earnings on 11/30/2024. The Earnings Whisper Score gives the statistical odds for the stock ahead of earnings. Calendar; Top-down. A look at earnings from the view of macro-economists and market technicians. Market Overview. Heat Map. Sentiment. Technicals. Retail Sales. Pricing.
WebApr 12, 2024 · A company’s earnings reviews provide a brief indication of a stock’s direction in the short term, where in the case of Altamira Therapeutics Ltd. No upward and no downward comments were posted in the last 7 days. On the technical side, indicators suggest CYTO has a 100% Sell on average for the short term. WebApr 11, 2024 · Altamira Therapeutics - CYTO Competitors $1.42 +0.20 (+16.39%) (As of 03/30/2024 02:30 PM ET) Compare Today's Range $1.26 $1.46 50-Day Range $1.21 $5.18 52-Week Range $1.17 $43.00 Volume 165,553 shs Average Volume 584,425 shs Market Capitalization $1.66 million P/E Ratio N/A Dividend Yield N/A Price Target N/A Profile …
WebFind the latest Earnings Report Date for Altamira Therapeutics Ltd. Common Shares 0.01 SF (Bermuda) (CYTO) at Nasdaq.com. WebAltamira Therapeutics Ltd. engages in developing therapeutics that address various unmet medical needs. Its commercial products include Bentrio, a drug-free nasal spray for personal protection against airborne viruses and allergens. The company is also involved in the development of RNA therapeutics for extrahepatic therapeutic targets ...
WebAltamira Therapeutics (CYTO) (Delayed Data from NSDQ) $1.44 USD +0.11 (8.27%) Updated Mar 16, 2024 03:59 PM ET After-Market: $1.38 -0.06 (-4.17%) 7:58 PM ET Add to portfolio Zacks Rank: Style...
WebFind the latest Altamira Therapeutics Ltd. (CYTO) stock quote, history, news and other vital information to help you with your stock trading and investing. grade 8 scholarships 2023Web2 days ago · View All Zacks #1 Ranked Stocks. Altamira Therapeutics (CYTO) Quote Overview » More Research » Altamira Therapeutics (CYTO) Price Target Stock Forecast. Trades from $ 1. grade 8 recording sheetWebApr 13, 2024 · Altamira Therapeutics ( NASDAQ:CYTO – Get Rating) and Viracta Therapeutics ( NASDAQ:VIRX – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, profitability, analyst recommendations, earnings, … grade 8 ratio word problemsWebCompany’s earnings for a period net of operating costs, taxes, and interest. -3.65M. -8.17%. Net profit margin. Measures how much net income or profit is generated as a percentage of revenue ... grade 8 quarter 3 healthWebAbout Earnings Date. Nasdaq provides visual representation of analyst expected earnings growth. Read our earnings report guide before you consider the forecast information when making investment ... grade 8 scholarships for 2023 in gautengWebMar 31, 2024 · 2024 Annual Report & Stockholder Meeting & Information 2024 Letter from the CEO ANNUAL REPORT 2024 Annual Report CORPORATE PRESENTATION Corporate Presentation March 2024 … grade 8 science e thaksalawaWeb2 days ago · Altamira Therapeutics Ltd. (CYTO) is up over 80% at $2.38. Rosecliff Acquisition Corp I (RCLF) is up over 22% at $12.85. Horizon Acquisition Corporation II … chilterns 100